This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n8http://linked.opendata.cz/resource/drugbank/drug/DB07848/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07848/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07848/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07848/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07848/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07848
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB07848 n14:DB07848
dcterms:title
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE
adms:identifier
n7:7828174 n8:DB07848 n9:99444319 n10:GSQ n11:9549257
n3:IUPAC-Name
n4:271B451D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4523-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4522-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B451F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4520-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4521-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B451B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B451C-363D-11E5-9242-09173F13E4C5 n4:271B4519-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B451A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4529-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B452A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4524-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4525-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4527-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4526-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4528-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B452F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4531-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4532-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B452E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B452D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4530-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B451E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B452B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B452C-363D-11E5-9242-09173F13E4C5